Extended from our previously studies showing that concurrent blockage of the NF-κB and Akt signaling pathways sensitized cancer cells to cisplatin-induced cell death, we investigated cisplatin response regulation mechanism and found that all histone H4- coding genes were down-regulated in NF-κB- and Akt-blocked cells. The gene discussed is NFKB1; the disease is cancer.